Literature DB >> 25965110

Difficult-to-cure populations with chronic hepatitis C: Vanishing in the direct-acting antiviral era?

Norah Terrault1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25965110     DOI： 10.1002/hep.27892

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

1.  Successful treatment of hepatitis C, genotype 3, with sofosbuvir/ledipasvir in decompensated cirrhosis complicated by mixed cryoglobulinaemia.

Authors:  Jennifer A Flemming; Catherine E Lowe
Journal:  BMJ Case Rep       Date:  2016-06-09

2.  Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS).

Authors:  Anne C Moorman; Xin Tong; Philip R Spradling; Loralee B Rupp; Stuart C Gordon; Mei Lu; Eyasu H Teshale; Joseph A Boscarino; Connie M Trinacty; Mark A Schmidt; Fujie Xu; Scott D Holmberg
Journal:  Dig Dis Sci       Date:  2016-05-23       Impact factor: 3.199

3.  Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies.

Authors:  Miguel Malespin; Tamara Benyashvili; Susan L Uprichard; Alan S Perelson; Harel Dahari; Scott J Cotler
Journal:  Therap Adv Gastroenterol       Date:  2016-10-17       Impact factor: 4.409

4.  A Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection.

Authors:  Yutaka Kishida; Naohiko Imaizumi; Hirohisa Tanimura; Shinichiro Kashiwamura; Toru Kashiwagi
Journal:  Int J Mol Sci       Date:  2016-03-09       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.